Nkarta, Inc.
A New Way Forward for Autoimmune Disease
157 employees · est. 2015 · South San Francisco, United...
Tmunity Therapeutics
Pioneering the future of immunotherapy through innovative T cell engineering to tackle a diverse array of diseases.
12 employees · est. 2015
Nkarta, Inc. is the larger of the two.
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | Nkarta, Inc. | Tmunity Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2015 |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Not tracked yet |
| Employees | ||
| Employees | 157 larger | 12 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Acquired |
| Total Funding | ||
| Total Funding | $595.00M | $220.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 6 |
| Services | ||
| Services | Development of immunotherapy drugs, Conducting clinical trials, Research and development of NK cell technology | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with autoimmune diseases, Healthcare providers, Medical researchers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Allogeneic NK Cells, Cell Therapy, Immuno-Oncology, Tumor Targeting, Cell Engineering, Cryopreservation, Cell Expansion, Hematologic Malignancies, Solid Tumor Malignancies, Therapy Manufacturing, Cancer Research, Natural Killer Cells, Oncology Therapeutics, Autoimmune Disease Treatment | Immunotherapy, T Cell Engineering, T Cell Receptor (TCR), Regulatory T Cells (Treg), Universal Engineered T Cells, Genetically Engineered T Cells, Oncology, Infectious Diseases, Autoimmune Disorders, Clinical Trials, Cell And Gene Therapy, Peripheral Blood T Cells, Cord Blood T Cells, Tumor Derived T Cells, Multi-center Clinical Studies |
| Website | ||
| Website | nkartatx.com | tmunity.com |
About Nkarta, Inc.
Nkarta, Inc., founded in 2015, is at the forefront of innovative biotechnology solutions aimed at tackling autoimmune diseases. Their slogan, "A New Way Forward for Autoimmune Disease", reflects their pioneering approach in the Biotechnology and Health Care sectors. The company specializes in devel...
About Tmunity Therapeutics
Tmunity Therapeutics, founded in 2015, is at the forefront of biotech innovation, striving to reshape the landscape of immunotherapy through its pioneering work in T cell engineering. The company emphasizes T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered...
We will tell you when either one moves
BounceWatch watches Nkarta, Inc. and Tmunity Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Nkarta, Inc. and Tmunity Therapeutics — by email.
Frequently Asked Questions
Compare Nkarta, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Nkarta, Inc. on 22 Jun 2026, and Tmunity Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
